During OGTTs, glucose-stimulated insulin secretion curves showed that the level of insulin secretion in women with MetS was significantly higher than that in healthy subjects and showed a peak delay; moreover, the area under the curve for insulin (AUCi) was increased in comparison with healthy subjects, which also confirmed the existence of IR in patients with MetS (Figure 4(b)). The gene discussed is INS; the disease is metabolic syndrome.